Product Code: BIO089E
Highlights:
The global sample preparation in genomics, proteomics, and epigenomics market should reach $7.4 billion by 2027 from $5.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.4% for the forecast period of 2022 to 2027.
Instruments segment of the global sample preparation in genomics, proteomics, and epigenomics market is expected to grow from $2.1 billion in 2022 to $2.8 billion in 2027 at a CAGR of 5.8% for the forecast period of 2022 to 2027.
Consumables segment of the global sample preparation in genomics, proteomics, and epigenomics market is expected to grow from $1.4 billion in 2022 to $2.0 billion in 2027 at a CAGR of 7.9% for the forecast period of 2022 to 2027.
Report Scope:
This research report categorizes the market for sample preparation in genomics, proteomics, and epigenomics by product segment. The major product segments are instruments, consumables, accessories, and sample preparation kits. The instruments segment is subdivided into workstations, liquid handling systems, extraction systems, and other instruments. Consumables are divided into columns, filters, tubes, plates, and other consumables. Sample preparation kits are segmented into purification kits, isolation kits, extraction kits, and others.
The global market for sample preparation is segmented by end user into research centers, academic institutes, government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. The markets in North America, Europe, Asia-Pacific, and Rest of the World (RoW) are covered. The market is also segmented by application into genomics, proteomics, and epigenomics.
Report Includes:
- 71 data tables and 51 additional tables
- Detailed overview and an up-to-date analysis of the global markets for sample preparation devices and consumables in genomics, proteomics, and epigenomics research and applications
- Analyses of the global market trends with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and market forecast for sample preparation instruments and consumables in USD million values, and their corresponding market share analysis by product, application segment, end-user, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
- Review of the recent breakthrough innovations, key technological issues, market regulations, and current status of the intellectual property rights on various instruments and consumables and applications of sample preparation products
- Insight into recent industry structure for the sample preparation market, competitive aspects of each product segments, R&D activities, and major growth strategies adopted in the global market
- Analysis of the competitive environments, new potential markets for novel products and assay developments in the sample preparation industry, and company value share analysis based on their segmental revenues
- Identification of future demand for various sample preparation reagents and products and analysis of target markets
- Descriptive company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Roche and Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing the Study
- 1.3 What's New in This Update?
- 1.4 Scope of Report
- 1.5 Intended Audience
- 1.6 Research Methodology
- 1.7 Geographic Breakdown
- 1.8 Analyst's Credentials
- 1.9 BCC Custom Research
- 1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
- 3.1 Introduction
- 3.2 Historical Perspective
- 3.3 Definitions
- 3.3.1 Genomics
- 3.3.2 Proteomics
- 3.3.3 Epigenomics
- 3.3.4 Sample Preparation
- 3.3.5 Molecular Biology
- 3.3.6 DNA Structure
- 3.3.7 DNA Replication
- 3.3.8 Proteins
- 3.4 Central Principles
- 3.5 Genomics
- 3.5.1 Comparative Genomics
- 3.5.2 Functional Genomics
- 3.5.3 Structural Genomics
- 3.6 Proteomics
- 3.6.1 Expression Proteomics
- 3.6.2 Structural Proteomics
- 3.6.3 Functional Proteomics
- 3.7 Epigenomics
- 3.8 Trends in R&D
- 3.8.1 Global Spending on R&D
- 3.8.2 Increase in R&D Spending on Healthcare
- 3.8.3 China: A Rising Hub for Science and Technology
- 3.8.4 R&D Funding
- 3.8.5 Global Increase in the Number of Researchers
- 3.9 Market Dynamics
- 3.9.1 Drivers
- 3.9.2 Restraints
- 3.9.3 Opportunities
- 3.9.4 Challenges
- 3.9.5 Limitations of Sample Preparation
Chapter 4 Impact of COVID-19 Pandemic
Chapter 5 Market Breakdown by Product Segment
- 5.1 Instruments
- 5.1.1 Global Market for Instruments by Type
- 5.1.2 Regional Markets for Instruments
- 5.1.3 Instrument Market Subsegments
- 5.2 Consumables
- 5.2.1 Regional Markets for Consumables
- 5.2.2 Market for Consumables by Product Type
- 5.3 Accessories
- 5.3.1 Regional Markets for Accessories
- 5.4 Sample Preparation Kits
- 5.4.1 Regional Markets for Sample Preparation Kits
- 5.4.2 Market for Sample Preparation Kits by Product Segment
Chapter 6 Market Breakdown by Application Segment
- 6.1 Genomics Applications
- 6.1.1 Medicine
- 6.1.2 Agriculture
- 6.2 Proteomics Applications
- 6.2.1 Oncology
- 6.2.2 Biomedical
- 6.2.3 Agriculture
- 6.2.4 Food Microbiology
- 6.3 Epigenomics Applications
Chapter 7 Market Breakdown by End User
- 7.1 Research Centers, Academic Institutes, and Government Agencies
- 7.2 Hospitals and Clinics
- 7.3 Pharmaceutical and Biotechnology Companies
- 7.4 Others
Chapter 8 Market Breakdown by Region
- 8.1 North America
- 8.1.1 National Institutes of Health
- 8.1.2 Decreasing R&D Spending
- 8.1.3 Growing Genetic Testing Market
- 8.1.4 Genetically Modified Crops
- 8.1.5 Government and Private Initiatives
- 8.1.6 Drug Discovery Driving the Market for Proteomics
- 8.1.7 Canada
- 8.1.8 Epigenomics
- 8.2 Europe
- 8.2.1 European 1+ Million Genome Initiative
- 8.2.2 Public Health Genomics European Network (PHGEN)
- 8.2.3 $3.4 Million Investment into Three-Dimensional Genomics
- 8.2.4 United Kingdom
- 8.2.5 U.K. 100,000 Genomes Project
- 8.2.6 Impact of Brexit
- 8.2.7 France
- 8.2.8 Germany
- 8.2.9 Rest of the Europe
- 8.2.10 New International Genome Research Centre in Denmark
- 8.3 Asia-Pacific
- 8.3.1 Genome Asia-Pacific 100K Initiative
- 8.3.2 Asia-Pacific: A New Hub for R&D
- 8.3.3 Global Collaboration Required
- 8.3.4 Australia
- 8.3.5 China
- 8.3.6 China Leading Asia-Pacific and Positioned to Lead World Genomics
- 8.3.7 Japan
- 8.3.8 Rest of Asia
- 8.3.9 Rest of the World
- 8.3.10 Middle East
- 8.3.11 Latin American Countries
Chapter 9 Company Profiles
- AGILENT TECHNOLOGIES INC.
- BIO-RAD LABORATORIES INC.
- DANAHER CORP.
- HAMILTON CO.
- ILLUMINA INC.
- MERCK MILLIPORE
- NORGEN BIOTEK CORP.
- PERKINELMER INC.
- PRESSURE BIOSCIENCES INC.
- PROMEGA CORP.
- QIAGEN GMBH
- ROCHE
- TECAN GROUP LTD.
- THERMO FISHER SCIENTIFIC INC.
- WATERS CORP.
Chapter 10 Competitive Landscape
Chapter 11 Appendix: List of Acronyms